In breast cancer SRAP is overexpressed and associated with worse prognosis,104 while in prostate cancer it has been shown to potentiate the activity of the androgen receptor.105 Due to intron 1 retention,106 the SRA1 gene expresses lincRNA-SRA as well. This evidence concerns the gene SRA1 and breast carcinoma.